title: Response to the questions submitted by Mr. Reichmann.
authors.affiliation: Keck School of Medicine, University of Southern California, Department of Maternal-Fetal Medicine, Los Angeles, CA, USA; David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Electronic address: mfejzo@mednet.ucla.edu.
authors.forename: Marlena
authors.initials: M
authors.lastname: Fejzo
authors.affiliation: HER Foundation, Damascus, OR, USA.
authors.forename: Kimber
authors.initials: K
authors.lastname: MacGibbon
authors.affiliation: Keck School of Medicine, University of Southern California, Department of Maternal-Fetal Medicine, Los Angeles, CA, USA.
authors.forename: Patrick
authors.initials: P
authors.lastname: Mullin
mesh_terms: D005260:Female; D005333:Fetus; D006801:Humans; D017294:Ondansetron; D011247:Pregnancy; D011295:Prenatal Care; D014481:United States
chemical_list: D017294:Ondansetron